Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Operating income as a share of revenue. US dollars at each year's exchange rate.
| Measure | electroCore, Inc.✕ ECOR · #19,820 in the world | Alcon Inc.✕ ALC · #705 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇨🇭 Switzerland |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments | Medical Instruments |
| Founded | — | 1945 |
| Size | ||
| Market cap | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | electroCore, Inc. | Alcon Inc. |
|---|---|---|
| 2025 | -41.1%SEC | 13.1%SEC |
| 2024 | -48.3%SEC | 14.3%SEC |
| 2023 | -120.2%SEC | 11.0%SEC |
| 2022 | -266.2%SEC | 7.7%SEC |
| 2021 | -367.7%SEC | 7.0%SEC |
| 2020 | -707.1%SEC | -7.1%SEC |
| 2019 | — | -2.5%SEC |
| 2018 | — | -3.5%SEC |
| 2017 | — | -1.1%SEC |
| 2010 | — | 34.5%SEC |
| 2009 | — | 34.8%SEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $75 M |
| $37.1 B |
| Revenue | $32 M | $10.4 B |
|---|
| Net income | $-14 M | $980 M▲ best |
|---|
| Employees | 83 | 25,000 |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | — | 37.9× |
| Price to sales | 2.0× | 3.6× |
| Price to book | — | 1.7× |
| Free cash flow yield | -11.0% | 4.7%▲ best |
| Profitability | ||
|---|---|---|
| Gross margin | 86.8%▲ best | 55.2% |
| Operating margin | -41.1% | 13.1%▲ best |
| Net margin | -43.6% | 9.4%▲ best |
| Return on equity | — | 4.5% |
| Growth | ||
|---|---|---|
| Revenue growth | 27.2%▲ best | 4.9% |
| Revenue growth, 3 years a year | 55.1%▲ best | 6.1% |
| Earnings per share growth | — | -3.4% |
| Financial strength | ||
|---|---|---|
| Debt to equity | — | 0.2× |
| Cash | ||
|---|---|---|
| Free cash flow margin | -25.8% | 16.6%▲ best |
| Altman Z-score zone | distress | — |
|---|
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.